Fierce Healthcare August 1, 2023
Paige Minemyer

Signify Health is expanding its services with the addition of a new in-home testing option for chronic kidney disease.

The company, which recently joined the fold at CVS Health, will provide in-home health evaluations to its Medicare Advantage members at no additional cost, including urinalysis and estimated glomerular filtration rate testing, according to an announcement given first to Fierce Healthcare.

The goal is to better support early detection, diagnosis and management of kidney disease, which is a leading cause of morbidity and mortality for Medicare Advantage enrollees.

Heidi Schwarzwald, M.D., senior vice president and chief medical officer of Signify Health Home and Community Services, told Fierce Healthcare that the testing will fit seamlessly into its existing in-home examination. A provider...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Home, Insurance, Medicare Advantage, Patient / Consumer, Post-Acute Care, Provider
Palliative Care’s ‘Endless Opportunities’ to Grow
Senators Urge Federal Government to Explore More Oversight of Medicaid in Assisted Living
St. Croix Hospice Adds 10 New Locations in Q1 2025
Argentum CEO: 2025 a ‘Year of Change’ Amid Uncertainty Over Spending Cuts, Immigration
‘Long-Term Harm’: Former CMS Chief Warns HHS Cuts Will Impact Nursing Home Surveys, MA Oversight

Share This Article